These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 29247050)
21. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes. Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989 [TBL] [Abstract][Full Text] [Related]
22. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility. Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578 [TBL] [Abstract][Full Text] [Related]
23. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor. Eltit JM; Bannister RA; Moua O; Altamirano F; Hopkins PM; Pessah IN; Molinski TF; López JR; Beam KG; Allen PD Proc Natl Acad Sci U S A; 2012 May; 109(20):7923-8. PubMed ID: 22547813 [TBL] [Abstract][Full Text] [Related]
24. Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. Weiss RG; O'Connell KM; Flucher BE; Allen PD; Grabner M; Dirksen RT Am J Physiol Cell Physiol; 2004 Oct; 287(4):C1094-102. PubMed ID: 15201141 [TBL] [Abstract][Full Text] [Related]
25. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95). Ta TA; Pessah IN Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049 [TBL] [Abstract][Full Text] [Related]
26. Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice. Aleman M; Zhang R; Feng W; Qi L; Lopez JR; Crowe C; Dong Y; Cherednichenko G; Pessah IN Mol Pharmacol; 2020 Oct; 98(4):351-363. PubMed ID: 32764093 [TBL] [Abstract][Full Text] [Related]
32. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree. Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602 [TBL] [Abstract][Full Text] [Related]
33. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors. Censier K; Urwyler A; Zorzato F; Treves S J Clin Invest; 1998 Mar; 101(6):1233-42. PubMed ID: 9502764 [TBL] [Abstract][Full Text] [Related]
34. The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle. Foster PS; Denborough MA Int J Biochem; 1993 Apr; 25(4):495-504. PubMed ID: 7682190 [TBL] [Abstract][Full Text] [Related]